APA (7th ed.) Citation

JC, M., MDGB, C., AMM, R., AMGD, C., LLN, P., S, F. D. S., . . . MR, S. (2023). Active Pharmacovigilance Project on the safety profile of Dolutegravir in Brazil. AIDS care, 35(5), 729. https://doi.org/10.1080/09540121.2022.2062289

Chicago Style (17th ed.) Citation

JC, Mendes, Ceccato MDGB, Reis AMM, Costa AMGD, Pantuzza LLN, Furtado Dos Santos S, Crepalde-Ribeiro K, and Silveira MR. "Active Pharmacovigilance Project on the Safety Profile of Dolutegravir in Brazil." AIDS Care 35, no. 5 (2023): 729. https://doi.org/10.1080/09540121.2022.2062289.

MLA (9th ed.) Citation

JC, Mendes, et al. "Active Pharmacovigilance Project on the Safety Profile of Dolutegravir in Brazil." AIDS Care, vol. 35, no. 5, 2023, p. 729, https://doi.org/10.1080/09540121.2022.2062289.